Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026)
Apogee Therapeutics' (APGE) quarterly EPS (Basic) came in at -$1.06 in Q1 2026, down 11.87% year-on-year from -$1.21 in Q1 2025, and up 6.96% on a QoQ basis from -$1.14 in Q4 2025.
Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of EPS (Basic) data on file, last reported at -$1.06 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 11.87% year-over-year to -$1.06 in Q1 2026; TTM through Mar 2026 was -$3.94, a 11.68% decrease from a year earlier, with the FY2025 full-year figure at -$4.22, down 27.74% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.06, up from -$1.14 in the prior quarter.
- Over the last five years, EPS (Basic) for APGE reached as high as -$0.51 in Q3 2023 and fell as low as -$9.46 in Q3 2022.
- Historically, EPS (Basic) has averaged -$2.09 across 5 years, with a median of -$1.14 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 94.65% in 2023 and fell as far as 159.98% in 2023.
- Year by year, EPS (Basic) stood at -$5.69 in 2022, then jumped by 77.69% to -$1.27 in 2023, then increased by 4.04% to -$1.22 in 2024, then rose by 6.12% to -$1.14 in 2025, then climbed by 6.96% to -$1.06 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.06 in Q1 2026, -$1.14 in Q4 2025, and -$1.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Apogee Therapeutics | 9.36 Bn | 8.30 Bn | - | -1.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -1.11 |
| Jun 30, 2025 | -1.13 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -1.22 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -1.27 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -3.78 |
| Mar 31, 2023 | -2.51 |
| Dec 31, 2022 | -5.69 |
| Sep 30, 2022 | -9.46 |
| Jun 30, 2022 | -1.45 |